Those receiving the drug were found to be 33 per cent less likely to suffer a heart attack when compared to patients on another type 2 diabetes medication

Those receiving the drug were found to be 33 per cent less likely to suffer a heart attack when compared to patients on another type 2 diabetes medication

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged…

Those receiving the drug were found to be 33 per cent less likely to suffer a heart attack when compared to patients on another type 2 diabetes medication